Aligos Therapeutics, Inc. (ALGS)
5.76
-0.45
(-7.25%)
USD |
NASDAQ |
Sep 08, 16:00
6.40
+0.64
(+11.11%)
After-Hours: 07:04
Aligos Therapeutics Price : 5.76 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 6.21 | 6.340 | 5.62 | 5.76 | 64235.00 |
| Sep 04, 2026 | 6.16 | 6.21 | 6.02 | 6.21 | 20289.00 |
| Sep 03, 2026 | 6.22 | 6.48 | 6.07 | 6.22 | 42077.00 |
| Sep 02, 2026 | 6.15 | 6.64 | 6.01 | 6.21 | 55406.00 |
| Sep 01, 2026 | 5.76 | 6.22 | 5.61 | 6.09 | 101645.0 |
| Aug 31, 2026 | 6.83 | 6.83 | 5.86 | 5.86 | 98916.00 |
| Aug 28, 2026 | 7.025 | 7.10 | 6.640 | 6.91 | 39072.00 |
| Aug 27, 2026 | 7.44 | 7.495 | 6.820 | 7.07 | 80523.00 |
| Aug 26, 2026 | 7.37 | 7.72 | 7.04 | 7.51 | 68947.00 |
| Aug 25, 2026 | 6.93 | 7.538 | 6.71 | 7.47 | 93635.00 |
| Aug 24, 2026 | 6.61 | 7.00 | 6.40 | 6.93 | 33224.00 |
| Aug 21, 2026 | 6.48 | 6.798 | 6.40 | 6.67 | 52329.00 |
| Aug 20, 2026 | 6.77 | 7.006 | 6.35 | 6.44 | 62498.00 |
| Aug 19, 2026 | 6.74 | 7.085 | 6.67 | 6.89 | 77341.00 |
| Aug 18, 2026 | 6.50 | 6.84 | 6.482 | 6.76 | 110130.0 |
| Aug 17, 2026 | 6.90 | 7.00 | 6.51 | 6.575 | 50615.00 |
| Aug 14, 2026 | 6.77 | 6.97 | 6.58 | 6.89 | 67000.00 |
| Aug 13, 2026 | 6.95 | 7.04 | 6.66 | 6.77 | 95166.00 |
| Aug 12, 2026 | 7.38 | 7.55 | 6.75 | 7.00 | 190606.0 |
| Aug 11, 2026 | 7.58 | 7.82 | 7.15 | 7.28 | 237713.0 |
| Aug 10, 2026 | 5.74 | 7.71 | 5.73 | 7.65 | 615784.0 |
| Aug 07, 2026 | 5.50 | 6.15 | 5.25 | 5.59 | 335799.0 |
| Aug 06, 2026 | 4.18 | 5.60 | 4.18 | 5.51 | 293475.0 |
| Aug 05, 2026 | 4.74 | 4.87 | 4.67 | 4.74 | 71830.00 |
| Aug 04, 2026 | 4.68 | 4.81 | 4.61 | 4.75 | 81446.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.43 |
| Amgen, Inc. | 393.17 |
| Anika Therapeutics, Inc. | 21.04 |
| BioCryst Pharmaceuticals, Inc. | 9.065 |
| Imunon, Inc. | 1.54 |
Price Related Metrics
| PS Ratio | 1.90 |
| Price to Book Value | 1.127 |
| Earnings Yield | -127.0% |
| Market Cap | 35.92M |